Weil Helps Sanofi Buy Rare Diseases Co. For Up To $2.2B
French healthcare giant Sanofi SA said Tuesday that it will buy a U.S. company that creates therapies for so-called orphan diseases for approximately $2.2 billion in cash as it seeks to...To view the full article, register now.
Already a subscriber? Click here to view full article